Pfizer Inc Stock Alpha and Beta Analysis

PFE Stock  USD 25.72  0.12  0.47%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pfizer Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pfizer over a specified time horizon. Remember, high Pfizer's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pfizer's market risk premium analysis include:
Beta
0.14
Alpha
0.0381
Risk
1.35
Sharpe Ratio
0.0438
Expected Return
0.0592
Please note that although Pfizer alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Pfizer did 0.04  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Pfizer Inc stock's relative risk over its benchmark. Pfizer Inc has a beta of 0.14  . As returns on the market increase, Pfizer's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pfizer is expected to be smaller as well. At present, Pfizer's Enterprise Value Over EBITDA is projected to slightly grow based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 15.55, whereas Price Book Value Ratio is forecasted to decline to 1.62.

Pfizer Quarterly Cash And Equivalents

3.15 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Pfizer Backtesting, Pfizer Valuation, Pfizer Correlation, Pfizer Hype Analysis, Pfizer Volatility, Pfizer History and analyze Pfizer Performance.

Pfizer Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pfizer market risk premium is the additional return an investor will receive from holding Pfizer long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pfizer. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pfizer's performance over market.
α0.04   β0.14

Pfizer expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Pfizer's Buy-and-hold return. Our buy-and-hold chart shows how Pfizer performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Pfizer Market Price Analysis

Market price analysis indicators help investors to evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pfizer shares will generate the highest return on investment. By understating and applying Pfizer stock market price indicators, traders can identify Pfizer position entry and exit signals to maximize returns.

Pfizer Return and Market Media

The median price of Pfizer for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 26.01 with a coefficient of variation of 1.89. The daily time series for the period is distributed with a sample standard deviation of 0.49, arithmetic mean of 26.0, and mean deviation of 0.39. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 12038 shares by Boshoff Christoffel of Pfizer at 26.52 subject to Rule 16b-3
01/31/2025
2
Acquisition by Albert Bourla of 625 shares of Pfizer subject to Rule 16b-3
02/18/2025
3
2025 Research Report Global Epilepsy Drugs Market Projected to Reach 11.85 Billion by 2033, Driven by Increased Disease Prevalence and Innovative Treatments - R...
02/24/2025
4
U.S. patent appeals panel delivers loss to Moderna in mRNA vaccine case
03/05/2025
5
Pfizer Inc. Shares Sold by Bahl Gaynor Inc.
03/06/2025
 
Pfizer dividend paid on 7th of March 2025
03/07/2025
7
BioNTech posts 721M loss in 2024 due to low demand for COVID-19 vaccines
03/10/2025
8
ViiV Healthcare showcases leadership in long-acting injectables innovation at CROI 2025 with data on third-generation integrase inhibitor and highly potent caps...
03/11/2025
9
US tariffs on India will be a bitter pill to swallow
03/12/2025

About Pfizer Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pfizer or other stocks. Alpha measures the amount that position in Pfizer Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 2025 (projected)
Dividend Yield0.03130.05690.06330.0665
Price To Sales Ratio2.862.782.364.57

Pfizer Upcoming Company Events

As portrayed in its financial statements, the presentation of Pfizer's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pfizer's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Pfizer's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Pfizer. Please utilize our Beneish M Score to check the likelihood of Pfizer's management manipulating its earnings.
7th of May 2024
Upcoming Quarterly Report
View
6th of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
4th of February 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

Build Portfolio with Pfizer

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Pfizer technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Pfizer technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pfizer trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...